NCT07039357View on ClinicalTrials.gov

Reconfirming the Safety and Performance of the Glyconics-DS System in Known Populations With and Without Diabetes

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 30, 2025

Primary Completion Date

October 15, 2025

Study Completion Date

October 30, 2025

Conditions
Diabetes MellitusHealthy
Interventions
DEVICE

Near-infrared (spectroscopy) for non-invasive assessment of glycated keratin of nail

both interventions will be applied in both participant groups

Trial Locations (1)

Unknown

Barts Liver Centre, London

Sponsors

Lead Sponsor

Glyconics Ltd
All Listed Sponsors
collaborator

Queen Mary University of London

OTHER

lead

Glyconics Ltd

INDUSTRY

NCT07039357 - Reconfirming the Safety and Performance of the Glyconics-DS System in Known Populations With and Without Diabetes | Biotech Hunter | Biotech Hunter